Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,978 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

NCT07178457

Conditions: Brentuximab Vedotin, Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

NCT07168291

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma (DLBCL), +18 more
Locations: First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT07175415

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Risk-adapted Therapeutic Strategy in +1q NDMM

NCT07045168

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia

NCT07169565

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.

NCT07162571

Conditions: Acute Lymphobkastic Leukemia, B Cell Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations: State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Dermatology Minsk, Belarus

View Trial Details

Not Yet Recruiting

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

NCT07162532

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07159906

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient

NCT07157579

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL)- Non-Hodgins's Lymphoma (NHL), Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma

NCT07144657

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: National Taiwan University Hospital Taipei, None Selected, Taiwan

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions